Ajanta Pharma has reported results for third quarter ended December 31, 2013.
The company has reported 91.65% rise in its net profit at Rs 62.42 crore for the quarter as compared to Rs 32.57 crore for the same quarter in the previous year. Total income from operations of the company has increased by 31.18% at Rs 300.85 crore for quarter under review as compared to Rs 229.34 crore for the quarter ended December 31, 2012.
Ajanta Pharma is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.
The company has reported 91.65% rise in its net profit at Rs 62.42 crore for the quarter as compared to Rs 32.57 crore for the same quarter in the previous year. Total income from operations of the company has increased by 31.18% at Rs 300.85 crore for quarter under review as compared to Rs 229.34 crore for the quarter ended December 31, 2012.
Ajanta Pharma is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.
No comments:
Post a Comment